PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1 DURING HEMODIALYSIS WITH CELLULOSE MEMBRANES

被引:5
|
作者
FRITH, SE [1 ]
HOENICH, NA [1 ]
REDFERN, CPF [1 ]
GOODSHIP, THJ [1 ]
机构
[1] UNIV NEWCASTLE UPON TYNE, SCH MED, DEPT MED, NEWCASTLE UPON TYNE NE2 4HH, TYNE & WEAR, ENGLAND
来源
关键词
CHRONIC RENAL FAILURE; HEMODIALYSIS; HEMODIALYSIS MEMBRANE; BIOCOMPATIBILITY; INTERLEUKIN; 1; INTERLEUKIN 1 RECEPTOR ANTAGONIST;
D O I
10.1177/039139889401700906
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
An in vivo cross-over study has investigated plasma and cellular levels of IL-1 (IL-1 alpha IL-1 beta and IL-1Ra) when using Cuprophan (C) and cellulose triacetate (CTA) membranes to assess the roles of complement activation and dialysate endotoxin content in the induction of cytokines during the dialysis procedure. The mean C5a level during Cuprophan dialysis was 29.9 +/- 0.63 ng/ml (Mean +/- SEM), while for the cellulose triacetate dialysis was 3.09 +/- 0.7 ng/ml. The endotoxin content of the dialysate was 0.31 +/- 0.34 EU/ ml and 0.68 +/- 1.39 EU/ml. These two factors failed to produce measurable changes in plasma or cellular IL-1 alpha and IL-1 beta levels during treatment. The plasma IL-1Ra levels predialysis were similar to those for normal controls (CTA 769 +/- 156 ng/ml, C739 +/- 93, normal controls 635 +/- 33) with a considerable day to day variation. A membrane independent fall in plasma IL-1Ra at 15 minutes was noted (CTA 420 +/- 92 ng/ml, C 503 +/- 139) with a return to pre-dialysis levels by the end of treament. Cellular IL-1Ra levels pre-dialysis were similar to the normal group - (CTA 1904 +/- 291 ng/ml, C 1564 +/- 292 and normal control 1971 +/- 368). However, on average, the values when using cellulose triacetate were 655 +/- 623 pg/ml higher than for Cuprophan (p=0.03). These findings indicate that the measurement of plasma cytokine levels is of limited use in the study of cytokine induction by the haemodialysis procedure and that IL-1Ra may be a better indicator of the host response fo cytokine stimuli during treatment. However, a considerable infer-patient and intra-treatment variation is present and further studies are required to elucidate the factors involved.
引用
收藏
页码:478 / 487
页数:10
相关论文
共 50 条
  • [21] INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS THE HYPERCALCEMIA MEDIATED BY INTERLEUKIN-1
    GUISE, TA
    GARRETT, IR
    BONEWALD, LF
    MUNDY, GR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 (05) : 583 - 587
  • [22] Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease
    Cominelli, F
    Pizarro, TT
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 : 49 - 53
  • [23] Interleukin-1α, interleukin-1β and interleukin-1 receptor antagonist share a common U-shaped recognition epitope on interleukin-1 receptor surface
    Ma, Huaijun
    Liu, Jie
    Wu, Wei
    He, Ping
    JOURNAL OF MOLECULAR RECOGNITION, 2022, 35 (09)
  • [24] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    CLARK, BD
    MANCILLA, J
    DINARELLO, CA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (22) : 14147 - 14150
  • [25] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    MANCILLA, J
    CLARK, BD
    DINARELLO, CA
    CLINICAL RESEARCH, 1991, 39 (02): : A462 - A462
  • [26] HUMAN INTERLEUKIN-1 PRODUCTION DURING HEMODIALYSIS
    BINGEL, M
    LONNEMANN, G
    SHALDON, S
    KOCH, KM
    DINARELLO, CA
    NEPHRON, 1986, 43 (03): : 161 - 163
  • [27] LIPOPOLYSACCHARIDE INDUCES HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1 PRODUCTION IN THE SAME CELL
    ANDERSSON, J
    BJORK, L
    DINARELLO, CA
    TOWBIN, H
    ANDERSSON, U
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) : 2617 - 2623
  • [28] Relationship between interleukin-1 and interleukin-1 receptor antagonist during the development of fever in the rat
    Cartmell, T
    Poole, S
    Rothwell, NJ
    Luheshi, GN
    MOLECULAR MECHANISMS OF FEVER, 1998, 856 : 252 - 255
  • [29] Localisation of mRNA for interleukin-1 receptor and interleukin-1 receptor antagonist in the rat ovary
    Wang, LJ
    Brannstrom, M
    Cui, KH
    Simula, AP
    Hart, RP
    Maddocks, S
    Norman, RJ
    JOURNAL OF ENDOCRINOLOGY, 1997, 152 (01) : 11 - 17
  • [30] Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome
    Joseph G. Cannon
    Jonathan B. Angel
    Leslie W. Abad
    Edouard Vannier
    Maria D. Mileno
    Laura Fagioli
    Sheldon M. Wolff
    Anthony L. Komaroff
    Journal of Clinical Immunology, 1997, 17 : 253 - 261